Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition.

Saved in:
Bibliographic Details
Title: Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition.
Authors: Connelly MA; Johnson & Johnson Pharmaceutical Research and Development, Welsh & McKean Roads, Spring House, PA 19477-0776, USA. mconnell@its.jnj.com, Parry TJ, Giardino EC, Huang Z, Cheung WM, Chen C, Cools F, Van der Linde H, Gallacher DJ, Kuo GH, Sarich TC, Demarest KT, Damiano BP
Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2010 May; Vol. 55 (5), pp. 459-68.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4023
DOI:10.1097/FJC.0b013e3181cf03cb